- The Effect of Psychotherapies on Youth in Low- and Middle-Income Countries
- Depressive Symptoms Reduced With Psilocybin Single Moderate Dose
- Increased Overdose Risk Among Previously Incarcerated With Opioid, Stimulant Use Disorders
- Gepirone Under Review for Major Depressive Disorder
- Adolescent Sleep Patterns Associated With Increased Risk for Multiple Sclerosis
- Buprenorphine Dispensing Low for Youth
- US Proposes to Make COVID-19 Shot Annual, Much Like Flu Shot
- Longer to First Recurrence of Major Depression With Preventive Cognitive Therapy
- Combinatorial Treatments for PTSD and Substance Use Have Favorable Outcomes
- ACP Updates Clinical Guidelines for Major Depressive Disorder Treatment
- Rykindo Approved for Schizophrenia, Bipolar Disorder
- No Increase Identified in Overdose Deaths Involving Buprenorphine During COVID-19
Conference Coverage
MORE MEETINGS
Clinical Tools
Powered by
Powered by 
MORE CLINICAL TOOLS
Short-Term Psychodynamic Psychotherapy Plus Antidepressants For Patients With Depression
Review: Probiotics May Relieve Halitosis in Short Term
Placebo Has Significant Pain Reduction Effect in Cannabinoid Clinical Trials
Reliable Biomarkers Identified for Diagnosing Systemic Sclerosis-ILD
Melatonin Supplements Improve Irritable Bowel Syndrome Severity
Education Developed For You
VISIT THE PSYCHIATRY ADVISOR INSTITUTE
